Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.

el-Beltagi, H M; Martens, A C; Dahab, G M; Hagenbeek, A

el-Beltagi, H M; Martens, A C; Dahab, G M; Hagenbeek, A.

Affiliation

el-Beltagi HM; Hemato-Oncology/TNO, Erasmus University Rotterdam, The Netherlands.

Leukemia ; 7(11): 1795-800, 1993 Nov.

Article in En | MEDLINE | ID: mdl-8231248

Subject(s)

Antineoplastic Agents/therapeutic use; Leukemia, Myeloid, Acute/drug therapy; Phenylenediamines/therapeutic use; Animals; Antineoplastic Agents/administration & dosage; Benzamides; Bone Marrow Transplantation; Disease Models, Animal; Drug Screening Assays, Antitumor; Leukemia, Myeloid, Acute/therapy; Male; Phenylenediamines/administration & dosage; Rats; Rats, Inbred BN; Recurrence

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenylenediamines / Leukemia, Myeloid, Acute / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1993 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links